Prapti A Patel

  • 29 Citations
  • 4 h-Index
20092019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Prapti A Patel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Rectal Neoplasms Medicine & Life Sciences
Hemophagocytic Lymphohistiocytosis Medicine & Life Sciences
Azacitidine Medicine & Life Sciences
X Chromosome Inactivation Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
von Willebrand Factor Medicine & Life Sciences
Proxy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 29 Citations
  • 4 h-Index
  • 9 Article

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

Yalniz, F. F., Berdeja, J. G., Maris, M. B., Lyons, R. M., Reeves, J. A., Essell, J. H., Patel, P., Sekeres, M., Hughes, A., Mappa, S. & Garcia-Manero, G., Jan 1 2019, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Proxy
Therapeutics
Bone Marrow
Histone Deacetylase Inhibitors

Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier

Bradley, C. P., Chen, C., Oetjen, K. A., Yan, C., Panjwani, R., Hauffe, S., Calvo, K. R., Yuan, C., Patel, P. A., Montgomery, N. D., Foster, M. C., Battiwalla, M., Barrett, A. J., Gibbons, R. J. & Ito, S., Sep 10 2019, In : Blood Advances. 3, 17, p. 2627-2631 5 p.

Research output: Contribution to journalArticle

Open Access
X Chromosome Inactivation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Mutation
3 Citations (Scopus)

Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: Results of a phase 2 study

Garcia-Manero, G., Abaza, Y., Takahashi, K., Medeiros, B. C., Arellano, M., Khaled, S. K., Patnaik, M., Odenike, O., Sayar, H., Tummala, M., Patel, P., Maness-Harris, L., Stuart, R., Traer, E., Karamlou, K., Yacoub, A., Ghalie, R., Giorgino, R. & Atallah, E., Feb 26 2019, In : Blood Advances. 3, 4, p. 508-518 11 p.

Research output: Contribution to journalArticle

Open Access
Azacitidine
Acute Myeloid Leukemia
Disease-Free Survival
Leukemia
Confidence Intervals
4 Citations (Scopus)
radiation therapy
Lymphoma
Radiotherapy
chemotherapy
progressions

What's in a name? The heterogeneous clinical spectrum and prognostic factors in a cohort of adults with hemophagocytic lymphohistiocytosis

Prokesch, B. C., Nagalla, S., Ezzati, F., Tujios, S. R., Dominguez, A., Chen, W., Kershaw, C., Patel, P., de la Flor, C., Foster, J., Martin, A. A., de la Morena, M. T. & Wysocki, C. A., Jan 1 2018, (Accepted/In press) In : Transfusion and Apheresis Science.

Research output: Contribution to journalArticle

Hemophagocytic Lymphohistiocytosis
Names
Survival
T-Cell Lymphoma
Neoplasms